- Home
- APLT vs SHMD Comparison
APLT vs SHMD Comparison
Compare APLT & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- SHMD
- Stock Information
- Founded
- APLT 2016
- SHMD 1864
- Country
- APLT United States
- SHMD Germany
- Employees
- APLT N/A
- SHMD N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- SHMD
- Sector
- APLT Health Care
- SHMD
- Exchange
- APLT Nasdaq
- SHMD Nasdaq
- Market Cap
- APLT 178.6M
- SHMD 179.1M
- IPO Year
- APLT 2019
- SHMD N/A
- Fundamental
- Price
- APLT $1.30
- SHMD $4.19
- Analyst Decision
- APLT Buy
- SHMD
- Analyst Count
- APLT 5
- SHMD 0
- Target Price
- APLT $4.13
- SHMD N/A
- AVG Volume (30 Days)
- APLT 5.5M
- SHMD 597.6K
- Earning Date
- APLT 11-10-2025
- SHMD 01-01-0001
- Dividend Yield
- APLT N/A
- SHMD N/A
- EPS Growth
- APLT N/A
- SHMD N/A
- EPS
- APLT N/A
- SHMD N/A
- Revenue
- APLT $121,000.00
- SHMD $85,165,542.00
- Revenue This Year
- APLT N/A
- SHMD N/A
- Revenue Next Year
- APLT $5,935.35
- SHMD N/A
- P/E Ratio
- APLT N/A
- SHMD N/A
- Revenue Growth
- APLT N/A
- SHMD N/A
- 52 Week Low
- APLT $0.30
- SHMD $1.86
- 52 Week High
- APLT $10.62
- SHMD $4.69
- Technical
- Relative Strength Index (RSI)
- APLT 62.38
- SHMD 65.57
- Support Level
- APLT $1.16
- SHMD $3.67
- Resistance Level
- APLT $1.50
- SHMD $4.25
- Average True Range (ATR)
- APLT 0.15
- SHMD 0.59
- MACD
- APLT -0.01
- SHMD 0.07
- Stochastic Oscillator
- APLT 66.64
- SHMD 78.71
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).